Loading clinical trials...

COMPLETEDPhase 2NCT00878254

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

The investigator(s) hypothesize that Rituximab together with combination chemotherapy, followed by Rituximab maintenance therapy, will provide better disease control with improved response rates and o...

Lead sponsor: University of Miami•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 2

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974 · Acute Leukemia, Acute Myeloid Leukemia, and more

RECRUITINGPhase 2

Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

NCT05868395 · Mantle-cell Lymphoma

Active Not RecruitingPhase 3

Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas

NCT00877214 · Follicular Lymphomas, Immunocytomas, and more

COMPLETEDPhase 3

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

NCT03112174 · Mantle-Cell Lymphoma

COMPLETEDPhase 1/2

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

NCT03323151 · Mantle-Cell Lymphoma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 23, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment25

Start dateMar 2009

Last updatedJul 23, 2025

Condition

Mantle-Cell Lymphoma

Locations shown

University of Miami

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 23, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions